Skip to content

Circles

B

Biomolecular Life Holdings, Inc.

BIOM· OTC

B

BIOMBiomolecular Life Holdings, Inc.

BIOMBiomolecular Life Holdings, Inc.·Earnings record

Q2 2014

Source filing unavailable

Previous · Q1 2014 Next · Q3 2014

Q2 2014 · —

Revenue

$0.00

no prior Q2 2013 on file

Net Income

-$2.00M

no prior Q2 2013 on file

EPS Diluted

-$0.09

no prior Q2 2013 on file

Operating Income-$1,151,719—

Operating Cash Flowderived-$308,934—

Same quarter

no prior Q2 2013 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q3 ’13 Q4 ’13^d Q1 ’14Q2 ’14Q3 ’14 Q4 ’14^d Q1 ’15 Q2 ’15 Q3 ’15

Biomolecular Life Holdings, Inc. · CIK 1091326 · Engraved from SEC EDGAR

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Movers Indexes Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Changelog Circles Account Terms Privacy